Occlutech, a leading innovator of implants to treat structural heart disease, today announced that it has obtained European CE Mark approval for its Perimembranous Ventricular Septal Defect (PmVSD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results